The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates
Abstract
Background: The study aims to investigate the effect of combining silver nanoparticles (AGNPs) with different antibiotics on multi-drug resistant (MDR) and extensively drug resistant (XDR) isolates of Pseudomonas aeruginosa ( P. aeruginosa ) and to investigate the mechanism of action of AGNPs. Methods: AGNPs were prepared by reduction of silver nitrate using trisodium citrate and were characterized by transmission electron microscope (TEM) in addition to an assessment of cytotoxicity. Clinical isolates of P. aeruginosa were collected, and antimicrobial susceptibility was conducted. Multiple Antibiotic Resistance (MAR) index was calculated, and bacteria were categorized as MDR or XDR. Minimum inhibitory concentration (MIC) of gentamicin, ciprofloxacin, ceftazidime, and AGNPs were determined. The mechanism of action of AGNPs was researched by evaluating their effect on biofilm formation, swarming motility, protease, gelatinase, and pyocyanin production. Real-time PCR was performed to investigate the effect on the expression of genes encoding various virulence factors. Results: TEM revealed the spherical shape of AGNPs with an average particle size of 10.84 ± 4.64 nm. AGNPS were safe, as indicated by IC50 (42.5 µg /ml). The greatest incidence of resistance was shown against ciprofloxacin which accounted for 43% of the bacterial isolates. Heterogonous resistance patterns were shown in 63 isolates out of the tested 107. The MAR indices ranged from 0.077 to 0.84. Out of 63 P. aeruginosa isolates, 12 and 13 were MDR and XDR, respectively. The MIC values of AGNPs ranged from 2.65 to 21.25 µg /ml. Combination of AGNPs with antibiotics reduced their MIC by 5–9, 2–9, and 3-10Fold in the case of gentamicin, ceftazidime, and ciprofloxacin, respectively, with synergism being evident. AGNPs produced significant inhibition of biofilm formation and decreased swarming motility, protease, gelatinase and pyocyanin production. PCR confirmed the finding, as shown by decreased expression of genes encoding various virulence factors. Conclusion: AGNPs augment gentamicin, ceftazidime, and ciprofloxacin against MDR and XDR Pseudomonas isolates. The efficacy of AGNPs can be attributed to their effect on the virulence factors of P. aeruginosa . The combination of AGNPs with antibiotics is a promising strategy to attack resistant isolates of P. aeruginosa .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AgNPs damage membranes, respiratory enzymes, and nucleic acids and act synergistically with standard antibiotics against MDR P. aeruginosa.”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [196]
In the citing paper
“Recent reviews outline proteomic stress responses and dosing strategies that balance antimicrobial activity with host safety [195,196].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
Sánchez-López, E., Gomes, D., Esteruelas, G., Bonilla, L., Lopez-Machado, A. L., Galindo, R., Cano, A., Espina, M., Ettcheto, M., Camins, A., et al. (2020) · Nanomaterials · doi:10.3390/nano10020292 · Cited by 1,474
Research works printed but not linked: 46
- Sangani MH, Nakhaei Moghaddam M, Forghanifard M. Inhibitory effect of zinc oxide nanoparticles on pseudomonas aeruginosa biofilm formation. Nanomed J. 2015;2(2):1218.
- Fazeli N, Momtaz H. Virulence gene profiles of Multidrug-Resistant Pseudomonas aeruginosa isolated from Iranian hospital infections. Iran Red Crescent Med J. 2014;16(10):e15722. · doi:10.5812/ircmj.15722
- Fernebro J. Fighting bacterial infections-future treatment options. Drug Resist Updat. 2011;14(2):125–39. · DOI · Paper page
- Antunes LCM, Ferreira RBR, Buckner MMC, Finlay BB. Quorum sensing in bacterial virulence. Microbiol (Reading). 2010;156(8):2271–82. · DOI · Paper page
- Aghaei SS, Javadi A, Sharifi Y, Morovvati A, Detection of Exotoxin A, T Y, U. S genes of Pseudomonas aeruginosa isolates resistant to third-generation cephalosporins in clinical samples of hospitalized patients in hospitals of Qom city, Iran. Qom Univ Med Sci J. 2016;10(1):48–55.
- Abdelaziz AA, Elbanna TE, Sonbol FI, Gamaleldin NM, El Maghraby GM. Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation. Expert Opin Drug Deliv. 2015;12(2):163–80. · doi:10.1517/17425247.2014.942639
- Saleh MM, Sadeq RA, Latif HKA, Abbas HA, Askoura M. Zinc oxide nanoparticles inhibits quorum sensing and virulence in Pseudomonas aeruginosa. Afr Health Sci. 2019;19(2):2043–55. · DOI
- Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20(5):8856–74. · DOI · Paper page
- Biel MA, Sievert C, Usacheva M, Teichert M, Balcom J. Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms. Int Forum Allergy Rhinol. 2011;1(5):329–34. · DOI
- Jeyaraj M, Varadan S, Anthony KJP, Murugan M, Rajaa A, Gurunathan S. Antimicrobial and anticoagulation activity of silver nanoparticles synthesized from the culture supernatant of Pseudomonas aeruginosa. J Ind Eng Chem. 2013;19(4):1299–303. · doi:10.1016/j.jiec.2012.12.031
- Naz S, Gul A, Zia M. Toxicity of copper oxide nanoparticles: a review study. IET Nanobiotechnol. 2020;14(1):1–13. https://doi.org/10.1049/iet-nbt.2019.0176. PMID:31935671; PMCID: PMC8676634. · DOI · Paper page
- Yildirimer L, et al. Toxicology and clinical potential of nanoparticles. Nano Today. 2011;66:585–607. · DOI · Paper page
- Alavi M, et al. Antimicrobial applications of lichens: secondary metabolites and green synthesis of silver nanoparticles: a review. Nmb-journal. 2022;1(1):15–21.
- Taraszkiewicz A, Fila G, Grinholc M, Nakonieczna J. Innovative strategies to overcome biofilm resistance. Biomed Res Int. 2013;2013:150653. · DOI · Paper page
- Alavi M, et al. Synergistic combinations of metal, metal oxide, or metalloid nanoparticles plus antibiotics against resistant and non-resistant bacteria. Mnba J. 2022;1(1):1–9.
- Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms. Antimicrob Agents Chemother. 2014;58(10):5818–30. · DOI
- Markowska K, Grudniak AM, Krawczyk K, Wróbel I, Wolska KI. Modulation of antibiotic resistance and induction of a stress response in Pseudomonas aeruginosa by silver nanoparticles. J Med Microbiol. 2014;63(6):849–54. · DOI
- Naqvi SZ, Kiran U, Ali MI, Jamal A, Hameed A, Ahmed S, et al. Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria. Int J Nanomed. 2013;8:3187–95. · DOI · Paper page
- Rashid MU, Bhuiyan MKH, Quayum ME. Synthesis of silver nano particles (Ag-NPs) and their uses for quantitative analysis of vitamin C tablets. Dhaka Univ J Pharm Sci. 2013;12(1):29–33. · DOI · Paper page
- Subramani S, Vignesh S. MAR index study and MDR character analysis of a few golden staph isolates. Asian J Pharm Life Sci. 2012;2(2):151–4.
- Paul S, Bezbaruah RL, Roy MK, Ghosh AC. Multiple antibiotic resistance (MAR) index and its reversion in Pseudomonas aeruginosa. Lett Appl Microbiol. 1997;24(3):169–71. · DOI
- Davidson PM, Parrish ME. Methods for testing the efficacy of food antimicrobials. Food Technol. 1989;43(1):148–55.
- Fratini F, Mancini S, Turchi B, Friscia E, Pistelli L, Giusti G, et al. A novel interpretation of the Fractional Inhibitory Concentration Index: the case Origanum vulgare L. and Leptospermum scoparium J. R. Et G. Forst essential oils against Staphylococcus aureus strains. Microbiol Res. 2017;195:11–7. · DOI · Paper page
- Christensen BE, Kjosbakken J, Smidsrød O. Partial Chemical and physical characterization of two Extracellular Polysaccharides produced by Marine, Periphytic Pseudomonas sp. Strain NCMB 2021. Appl Environ Microbiol. 1985;50(4):837–45. · DOI
- Nurhafizah WWI, Lee KL, Laith AAR, Nadirah M, Danish-Daniel M, Zainathan SC, et al. Virulence properties and pathogenicity of multidrug-resistant Vibrio harveyi associated with luminescent vibriosis in Pacific white shrimp, Penaeus vannamei. J Invertebr Pathol. 2021;186:107594. · DOI
- Nasr RA, AbuShady HM, Hussein HS. Biofilm formation and presence of icaAD gene in clinical isolates of staphylococci. Egypt J med Hum Genet. 2012;13(3):269–74. · DOI
- Gupta RK, Setia S, Harjai K. Expression of quorum sensing and virulence factors are interlinked in Pseudomonas aeruginosa: an in vitro approach. Am J Biomed Sci. 2011;3(2):116–25. · DOI
- Vijayaraghavan P, Vincent SGP. A simple method for the detection of protease activity on agar plates using bromocresolgreen dye. J Biochem Tech. 2013;4(3):628–30.
- Das T, Manefield M. Pyocyanin promotes extracellular DNA release in Pseudomonas aeruginosa. PLoS ONE. 2012;7(10):e46718. · DOI · Paper page
- Seleem NM, Atallah H, Abd El Latif HK, Shaldam MA, El-Ganiny AM. Could the analgesic drugs, Paracetamol and indomethacin, function as quorum sensing inhibitors? Microb Pathog. 2021;158:105097. · doi:10.1016/j.micpath.2021.105097
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–8. · DOI · Paper page
- Thiruvengadam V, Bansod AV. Characterization of silver nanoparticles synthesized using chemical method and its antibacterial property. Biointerface Res Appl Chem. 2020;10(6):7257–64. · doi:10.33263/briac106.72577264
- Kvítek L, Panacek A, Prucek R, Soukupova J, Vanickova M, Kolar M et al. Antibacterial activity and toxicity of silver–nanosilver versus ionic silver. Journal of Physics: Conference Series. 2011;304(1):012029. · DOI
- Gad GF, El-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007;60(5):1010–17. · doi:10.1093/jac/dkm348
- Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev. 2019;32(4):e00031–19. · DOI · Paper page
- Khalil MA, El Maghraby GM, Sonbol FI, Allam NG, Ateya PS, Ali SS. Enhanced efficacy of some antibiotics in Presence of Silver Nanoparticles against Multidrug Resistant Pseudomonas aeruginosa recovered from burn Wound infections. Front Microbiol. 2021;12:648560. · DOI
- Uddén F, Filipe M, Reimer Å, Paul M, Matuschek E, Thegerström J, et al. Aerobic bacteria associated with chronic suppurative otitis media in Angola. Infect Dis Poverty. 2018;7(1):42. · doi:10.1186/s40249-018-0422-7
- Kalishwaralal K, BarathManiKanth S, Pandian SR, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces. 2010;79(2):340–44. · DOI · Paper page
- Siddique MH, Aslam B, Imran M, Ashraf A, Nadeem H, Hayat S, et al. Effect of silver nanoparticles on Biofilm formation and EPS production of Multidrug-resistant Klebsiella pneumoniae. Biomed Res Int. 2020;2020:6398165. · DOI · Paper page
- Oura H, Tashiro Y, Toyofuku M, Ueda K, Kiyokawa T, Ito S, et al. Inhibition of Pseudomonas aeruginosa swarming motility by 1-naphthol and other bicyclic compounds bearing hydroxyl groups. Appl Environ Microbiol. 2015;81(8):2808–18. · doi:10.1128/aem.04220-14
- Powell LC, Pritchard MF, Emanuel C, Onsøyen E, Rye PD, Wright CJ, et al. A nanoscale characterization of the interaction of a novel alginate oligomer with the cell surface and motility of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol. 2014;50(3):483–92. · DOI
- Topa SH, Subramoni S, Palombo EA, Kingshott P, Rice SA, Blackall LL. Cinnamaldehyde disrupts biofilm formation and swarming motility of Pseudomonas aeruginosa. Microbiol. 2018;164(9):1087–97. · DOI
- Molinari G, Guzman CA, Pesce A, Schito GC. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother. 1993;31(5):681–8. · doi:10.1093/jac/31.5.681
- El-Shounya WA, Moawad M, Haider AS, Ali S, Nouh S. Antibacterial potential of a newly synthesized zinc peroxide nanoparticles (ZnO2-NPs) to combat biofilm-producing multi-drug resistant Pseudomonas aeruginosa. Egypt J Bot. 2019;59(3):657–66.
- Najafi M, Nakhaei Moghaddam M, Yousefi E. The Effect of Silver nanoparticles on pyocyanin production of Pseudomonas aeruginosa isolated from clinical specimens. Avicenna J Med Biotechnol. 2021;13(2):98–103.
- Alavi M, Yarani R. ROS and RNS modulation: the main antimicrobial, anticancer, antidiabetic, and antineurodegenerative mechanisms of metal or metal oxide nanoparticles. Nmb J. 2023;2(1):22–30.
Cited by
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Kamer, A. M. A., El Maghraby, G. M., Shafik, M. M., & Al-Madboly, L. A.
- Venue
- BMC Microbiology
- Published
- 2024-07-26
- Volume
- 24
- Issue
- 1
- ISSN
- 1471-2180
- Cited by
- 38
- References
- 2
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Tanta University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates. https://app.cochat.ai/papers/10.1186/s12866-024-03397-z
- The paper
- Kamer, A. M. A., El Maghraby, G. M., Shafik, M. M., & Al-Madboly, L. A. (2024). Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates. BMC Microbiology. https://doi.org/10.1186/s12866-024-03397-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.